NCT04152018
Consider joining a clinical study for adults with head and neck squamous cell carcinoma or recurrent/refractory Renal Cell Carcinoma
People with metastatic HNSCC or recurrent/refractory RCC may benefit from medicines that boost the immune system to help find and fight off cancer cells (immunotherapy). Doctors are researching how potential new immunotherapy medicines may work together to treat HNSCC and RCC more effectively.
This study is evaluating if an investigational immunotherapy is safe and effective when taken with an anti-PD-1 antibody.
Who may participate
Each clinical study has its own guidelines for who can participate, called eligibility criteria. However, only the research study staff can determine if you qualify to enroll in the study.
What to expect
Study visits at months 1, 3, and 4 after completing treatment
Some studies require the study team to stay in contact with the participant for a period of time after the participant completes the main part of the study. This long-term follow up is to collect additional information on the study drug over time.
About the study medicine
Cancer treatment that boosts the body’s immune system to help it find and fight off cancer cells is called immunotherapy. The study medicine is a type of immunotherapy designed to block a specific protein in cancer cells that allows them to avoid attack by the immune system. Doctors are evaluating if taking this study medicine in addition to a PD-L1/PD-1 inhibitor (another immunotherapy) is more effective than current treatments in treating patients with HNSCC and RCC.
Frequently asked questions
How long will I be in the study?
The length of your participation in this study will vary based on how your cancer is responding to the treatment. You may continue treatment cycles until your cancer gets worse or the side effects become too uncomfortable. You will need to check in with the study team 1 month, 3 months, and 4 months after completing your final treatment.
What if this study is not right for me?
You can choose to leave the study at any time, for any reason. Choosing to leave the study will not affect your cancer treatment or future medical care. We encourage you to speak with your oncologist about all available treatment options.
What are the possible side effects?
All medicines have the potential to cause unwanted side effects. The study doctor will discuss the possible risks and benefits of participating in this study with you before you choose to enroll. You can choose to leave the study at any time.
What are my other options?
Instead of taking part in this study, you may choose to receive treatment with other medicines or therapies that have been approved to treat your type of cancer, or no treatment at all. The study doctor will discuss all your options with you and help decide what’s best for your specific situation.
Will I be paid for taking part in this study?
You will not receive payment for taking part in this study. However, you may be reimbursed for study-related expenses like parking, meals, or travel.
